Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines.
Moisan F, Longy M, Robert J, Le Morvan V. Moisan F, et al. Among authors: le morvan v. Br J Cancer. 2006 Oct 9;95(7):906-13. doi: 10.1038/sj.bjc.6603361. Epub 2006 Sep 19. Br J Cancer. 2006. PMID: 16983402 Free PMC article.
On the use of pharmacogenetics in cancer treatment and clinical trials.
Robert J, Le Morvan V, Giovannetti E, Peters GJ; PAMM Group of EORTC. Robert J, et al. Among authors: le morvan v. Eur J Cancer. 2014 Oct;50(15):2532-43. doi: 10.1016/j.ejca.2014.07.013. Epub 2014 Aug 4. Eur J Cancer. 2014. PMID: 25103456 Review.
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan].
Boyer JC, Etienne-Grimaldi MC, Thomas F, Quaranta S, Picard N, Loriot MA, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C. Boyer JC, et al. Among authors: le morvan v. Bull Cancer. 2014 Jun;101(6):533-53. doi: 10.1684/bdc.2014.1933. Bull Cancer. 2014. PMID: 24977443 Review. French.
Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models.
Laroche-Clary A, Le Morvan V, Yamori T, Robert J. Laroche-Clary A, et al. Among authors: le morvan v. Mol Cancer Ther. 2010 Dec;9(12):3315-21. doi: 10.1158/1535-7163.MCT-10-0673. Epub 2010 Oct 1. Mol Cancer Ther. 2010. PMID: 20889730
Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model.
Charasson V, Hillaire-Buys D, Solassol I, Laurand-Quancard A, Pinguet F, Le Morvan V, Robert J. Charasson V, et al. Among authors: le morvan v. Eur J Cancer. 2009 Sep;45(13):2391-401. doi: 10.1016/j.ejca.2009.05.013. Epub 2009 Jun 6. Eur J Cancer. 2009. PMID: 19501504
Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
Meynard D, Le Morvan V, Bonnet J, Robert J. Meynard D, et al. Among authors: le morvan v. Oncol Rep. 2007 May;17(5):1213-21. Oncol Rep. 2007. PMID: 17390068
Functional study of the 830C>G polymorphism of the human carboxylesterase 2 gene.
Bellott R, Le Morvan V, Charasson V, Laurand A, Colotte M, Zanger UM, Klein K, Smith D, Bonnet J, Robert J. Bellott R, et al. Among authors: le morvan v. Cancer Chemother Pharmacol. 2008 Mar;61(3):481-8. doi: 10.1007/s00280-007-0493-9. Epub 2007 May 5. Cancer Chemother Pharmacol. 2008. PMID: 17483951
Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity.
Moisan F, Laroche-Clary A, Auzanneau C, Ricard N, Pourquier P, Robert J, Le Morvan V. Moisan F, et al. Among authors: le morvan v. Carcinogenesis. 2012 May;33(5):962-8. doi: 10.1093/carcin/bgs107. Epub 2012 Feb 15. Carcinogenesis. 2012. PMID: 22345163
Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer.
Mathiaux J, Le Morvan V, Pulido M, Jougon J, Bégueret H, Robert J. Mathiaux J, et al. Among authors: le morvan v. Mol Diagn Ther. 2011 Jun 1;15(3):159-66. doi: 10.1007/BF03256406. Mol Diagn Ther. 2011. PMID: 21766907
[Biological bases for individualising prescriptions in oncology: the germline genome].
Robert J, Le Morvan V. Robert J, et al. Among authors: le morvan v. Bull Cancer. 2008 Oct;95(10):911-21. doi: 10.1684/bdc.2008.0722. Bull Cancer. 2008. PMID: 19004720 French.
34 results
Jump to page